J. Tanner, Y. Whang, J. Sample, A. Sears, E. Kieff: Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. In: Journal of Virology. Band62, Nr.12, 1. Dezember 1988, ISSN0022-538X, S.4452–4464, PMID 2460635 (asm.org [abgerufen am 30. April 2020]).
doi.org
Javier G. Ogembo, Lakshmi Kannan, Ionita Ghiran, Anne Nicholson-Weller, Robert W. Finberg: Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor. In: Cell Reports. Band3, Nr.2, Februar 2013, S.371–385, doi:10.1016/j.celrep.2013.01.023 (elsevier.com [abgerufen am 30. April 2020]).
L. S. Chesnokova, S. L. Nishimura, L. M. Hutt-Fletcher: Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins v 6 or v 8. In: Proceedings of the National Academy of Sciences. Band106, Nr.48, 1. Dezember 2009, ISSN0027-8424, S.20464–20469, doi:10.1073/pnas.0907508106 (pnas.org [abgerufen am 30. April 2020]).
Ascherio, Alberto et al.: Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. In: Science. 2022, doi:10.1126/science.abj8222.
Stephanie L. Grach, Jaime Seltzer, Tony Y. Chon, Ravindra Ganesh: Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. In: Mayo Clinic Proceedings. Band98, Nr.10, Oktober 2023, S.1545, doi:10.1016/j.mayocp.2023.07.032.
elsevier.com
linkinghub.elsevier.com
Javier G. Ogembo, Lakshmi Kannan, Ionita Ghiran, Anne Nicholson-Weller, Robert W. Finberg: Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor. In: Cell Reports. Band3, Nr.2, Februar 2013, S.371–385, doi:10.1016/j.celrep.2013.01.023 (elsevier.com [abgerufen am 30. April 2020]).
J. Tanner, Y. Whang, J. Sample, A. Sears, E. Kieff: Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. In: Journal of Virology. Band62, Nr.12, 1. Dezember 1988, ISSN0022-538X, S.4452–4464, PMID 2460635 (asm.org [abgerufen am 30. April 2020]).
Q. Li, M. K. Spriggs, S. Kovats, S. M. Turk, M. R. Comeau: Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. In: Journal of Virology. Band71, Nr.6, Juni 1997, ISSN0022-538X, S.4657–4662, PMID 9151859 (nih.gov [abgerufen am 30. April 2020]).
E. Maeda et al.: Spectrum of Epstein-Barr virus-related diseases: a pictorial review. In: Japanese Journal of Radiology. Band27. Jahrgang, Nr.1, 2009, S.4–19, PMID 19373526.
S. A. Rezk, L. M. Weiss: Epstein-Barr virus-associated lymphoproliferative disorders. In: Human Pathology. Band38. Jahrgang, Nr.9, 2009, S.1293–1304, PMID 17707260.
M. Roweet al.: Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. In: Seminars in Cancer Biology. Band19. Jahrgang, Nr.6, 2009, S.377–388, PMID 19619657.
D. Martin, J. S. Gutkind: Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. In: Oncogene. Band27. Jahrgang, Nr.2, 2008, S.31–42, PMID 19956178.
B. A. Bagert: Epstein-Barr virus in multiple sclerosis. In: Current Neurology and Neuroscience Reports. Band9. Jahrgang, Nr.5, 2009, S.405–410, PMID 19664371.
D. Pohl: Epstein-Barr virus and multiple sclerosis. In: Journal of the Neurological Sciences. Band286. Jahrgang, Nr.1–2, 2009, S.62–64, PMID 19361810.
F. Alarcón: Encephalitis lethargica due to Epstein-Barr virus infection. In: Movement Disorders. Band 26, Nr. 11, 2011, S. 2132–2134, PMID 21611982.
L. S. Chesnokova, S. L. Nishimura, L. M. Hutt-Fletcher: Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins v 6 or v 8. In: Proceedings of the National Academy of Sciences. Band106, Nr.48, 1. Dezember 2009, ISSN0027-8424, S.20464–20469, doi:10.1073/pnas.0907508106 (pnas.org [abgerufen am 30. April 2020]).
J. Tanner, Y. Whang, J. Sample, A. Sears, E. Kieff: Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. In: Journal of Virology. Band62, Nr.12, 1. Dezember 1988, ISSN0022-538X, S.4452–4464, PMID 2460635 (asm.org [abgerufen am 30. April 2020]).
L. S. Chesnokova, S. L. Nishimura, L. M. Hutt-Fletcher: Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins v 6 or v 8. In: Proceedings of the National Academy of Sciences. Band106, Nr.48, 1. Dezember 2009, ISSN0027-8424, S.20464–20469, doi:10.1073/pnas.0907508106 (pnas.org [abgerufen am 30. April 2020]).
Q. Li, M. K. Spriggs, S. Kovats, S. M. Turk, M. R. Comeau: Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. In: Journal of Virology. Band71, Nr.6, Juni 1997, ISSN0022-538X, S.4657–4662, PMID 9151859 (nih.gov [abgerufen am 30. April 2020]).